Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials (Q35747045)
Jump to navigation
Jump to search
scientific article published on 3 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials |
scientific article published on 3 February 2012 |
Statements
1 reference
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials (English)
1 reference
Donald P Tashkin
1 reference
Dennis E Doherty
1 reference
Edward Kerwin
1 reference
Carlos E Matiz-Bueno
1 reference
Barbara Knorr
1 reference
Tulin Shekar
1 reference
Davis Gates
1 reference
Heribert Staudinger
1 reference
3 February 2012
1 reference
7
1 reference
73-86
1 reference
1 February 2012
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference